SCI (SCI) Q3 2026 Earnings Call Transcript

Service Corporation International reported Q3 adjusted EPS of $0.97, up 11% year over year, and revenue of $1.11 billion, up 5%, but results were below management’s expectations amid weaker funeral volumes and rising costs. SCI cut its 2026 adjusted EPS guidance midpoint to about $3.99 from $4.20, citing funeral volumes projected roughly 200 basis points below initial expectations and higher expenses; it maintained adjusted operating cash flow guidance of $1.05 billion to $1.11 billion. Preneed sales grew 5% in cemeteries and 6% in funerals, while the company repurchased $53 million of shares in the quarter.

Analysis

The key issue is earnings quality and timing, not whether preneed demand is growing. Cemetery sales can expand the backlog while near-term earnings lag: selling compensation is expensed immediately, but revenue waits on delivery, and a greater mix of undeveloped property or merchandise extends that gap. Treat backlog growth as a future conversion option, not current margin protection; watch recognition rates and the cost to acquire each contract.

Near term (days to 1 quarter), lower funeral volumes and elevated healthcare, fuel, and promotional costs leave estimates vulnerable. Management’s market-share claim, if accurate, points to industry mortality volatility rather than SCI-specific share loss; it does not remove the risk that weak volumes persist. The Q4 volume read-through, followed by evidence on pricing realization and cost control, is the main 1–3 month catalyst. Over 6–18 months, demographic demand and backlog conversion could support growth, but only if recognition mix improves and fixed selling costs are absorbed.

Free cash flow is a partial cushion, not proof that EPS weakness is temporary: quarterly cash flow included working-capital timing, while annual cash taxes benefit from credits. Buybacks can support per-share results, but leverage near the top half of its stated target range argues against assuming repurchases fully offset operating pressure. Contrarian view: the earnings reset may overstate structural damage if volumes normalize and cemetery sales convert; conversely, the market may underprice how long cost/revenue timing can suppress margins.

Key Decisions for Investors

• Keep SCI tactically neutral-to-underweight rather than buying the backlog narrative immediately; reassess after Q4 volume data and early evidence that pricing offsets healthcare, fuel, and selling-cost inflation.
• Use the next quarter as a thesis checkpoint: upgrade only if funeral volumes stabilize and cemetery recognition/margins improve without sacrificing preneed sales growth. Falsification: continued volume weakness alongside further fixed-cost growth or another recognition-rate decline.
• Do not treat the free-cash-flow outlook as a clean earnings hedge. Verify the working-capital contribution, tax-credit impact, and preneed down-payment/installment collections in filings before extrapolating cash conversion.
• Monitor capital allocation: buybacks may cushion per-share earnings, but with net leverage at 3.7x, prefer evidence of operating improvement over authorization capacity as the bullish catalyst.